HL Financial Services’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

HL Financial Services’s Portfolio KERX Stock Details KERX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-26,000	Closed	-$88K	–	800
2018 Q3	$88K	Hold	26,000	–	–	﹤0.01%	739
2018 Q2	$98K	Buy	26,000 +3,000	+13%	+$14.6K	﹤0.01%	671
2018 Q1	$94K	Buy	23,000 +8,000	+53%	+$37.3K	﹤0.01%	682
2017 Q4	$70K	Buy	+15,000	New	+$82.7K	﹤0.01%	604

HL Financial Services's KERX Position: Q4 2018 in Review

HL Financial Services sold out of Keryx Biopharmaceuticals Inc (KERX) in Q4 2018, closing a stake of 26,000 shares — an estimated $88K sold.

HL Financial Services first reported a position in KERX in Q4 2017 and held it in 4 quarters. The position peaked at $98K in Q2 2018. 1 fund tracked by Wall St. Rank holds KERX as of Q4 2018.

HL Financial Services reported no remaining Keryx Biopharmaceuticals Inc position as of Q4 2018 after selling out during the quarter.
HL Financial Services sold 26,000 Keryx Biopharmaceuticals Inc shares in Q4 2018, an estimated $88K.
HL Financial Services first reported a position in Keryx Biopharmaceuticals Inc in Q4 2017 and held it in 4 quarters.
HL Financial Services's Keryx Biopharmaceuticals Inc position peaked at $98K in Q2 2018.
1 fund tracked by Wall St. Rank held Keryx Biopharmaceuticals Inc as of Q4 2018.

Based on HL Financial Services's 13F filing for Q4 2018, filed 7 Feb 2019.